Explore pioneering work in AI, cell therapy and immunotherapy, and our approach to compassionate, community-informed care in the 2024 Pathways to a Cure annual report.
Researchers Rebecca Kehm, PhD and Lauren Houghton, PhD, shed light on an emerging trend in early onset breast cancer, pointing to early adolescence as a key window that could provide needed answers.
A new advisory on how alcohol increases cancer risk addresses the growing body of evidence about alcohol’s harmful health impacts, including its direct link to cancer.
A study, led by Benjamin Izar, MD, is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung, and provides leads to why severe cases of COVID-19 experience long-term complications.
The biological reasons for racial disparities in breast cancer still aren’t fully understood, but a new study highlights a prognostic biomarker called Kaiso that may provide some insight.
Congratulations to Carol L. Prives, PhD, FAACR, who has been awarded the 2021 AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research by the American Association for Cancer Research.
Columbia researchers have been awarded Multi-PI Planning Grants to support the submission of multi-component biomedical research grants and large multi-PI research grants.
Congratulations to Dr. Scuoppo who has been awarded an ASH Restart Award to support his ongoing research in novel therapeutics for diffuse large B-cell lymphoma.
A new method that uses CRISPR to simultaneously make thousands of point mutations in human genes is helping researchers understand how subtle changes to genes contribute to cancer and other diseases.
Dr. Fatemeh Momen-Heravi is the recipient of a prestigious Science of the Patient grant to fund her research into the existing racial disparities in head and neck cancer.
Drs. Sankar Ghosh, Brent Stockwell, and Zhiguo Zhang are recipients of the translational research awards by the new partnership, Columbia-Sumitomo Dainippon Pharma Oncology Alliance.